Investigating the effects of ebselen, a potential new lithium mimetic, on glutamate transmission.

Filipa MotaTeresa SementaCarlotta TaddeiNatasha MosesJayanta BordoloiStefan HaderThomas EykynDiana CashFederico TurkheimerMattia VeroneseNisha Singh

Published in: Synapse (New York, N.Y.) (2020)

Ebselen, a potential new lithium-like drug, treatment reduced brain glutamate, as measured by PET imaging using the mGluR5 radioligand [18 F]FPEB in rats.

Keyphrases

pet imaging
white matter
emergency department
positron emission tomography
resting state
multiple sclerosis
climate change
brain injury
drug induced
smoking cessation